Better Therapeutics

company

About

Better develops prescription software for treating cardiometabolic diseases.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$50M
Industries
Artificial Intelligence,Biotechnology,Health Care,Information Technology,Therapeutics
Founded date
May 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Better Therapeutics discovers, develops and commercializes prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases. We use clinically-validated, FDA-regulated software to change the behaviors that cause these diseases thereby improving quality of life, reducing the need for medications, and lowering costs. Our products deliver digital behavioral therapy that integrates neuroscience, lifestyle medicine, and explainable AI into a physician-prescribed mobile medical app, and uses patient-generated data to inform clinical decision-making and improve treatment outcomes. Our current product pipeline includes therapeutic candidates for the treatment of type 2 diabetes, hypertension, and dyslipidemia.

Our founding team has started, led and exited multiple technology companies that have transformed industries and generated billions of dollars in enterprise value. The 17th Surgeon General of the US, Dr. Richard Carmona, serves as an independent board director.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Better Therapeutics has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Aug 25, 2021 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 25, 2021 Debt Financing $50M 1 Hercules Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Better Therapeutics is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Debt Financing